The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and AutophagyBirgit Lohberger, Beate Rinner|PLoS ONE|2016Cited by 22
In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma MetastasisMaximiliane Wußmann, Beate Rinner|Biomedicines|2022Cited by 1